Literature DB >> 6852103

Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.

J E Leysen, W Gommeren, F De Clerck.   

Abstract

[3H]Ketanserin showed substantial binding to cat platelet membranes; 40% of this was specific binding, characterized by a plateau in serotonin antagonist inhibition curves, and another 40% was non-specific binding to structural recognition sites displaceable by unlabelled ketanserin. Specific [3H]ketanserin binding to platelets shows the features of serotonin S2-receptor binding sites previously identified in rat pre-frontal cortex and in striatum. In platelets, KD = 1.02 nM and Bmax = 86 fmol/10(9) platelets; the Ki values of 21 compounds were similar in the three different tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852103     DOI: 10.1016/0014-2999(83)90401-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Human platelet 5-HT2 receptor binding sites re-evaluated: a criticism of current techniques [corrected].

Authors:  T Steckler; K Rüggeberg-Schmidt; B Müller-Oerlinghausen
Journal:  J Neural Transm Gen Sect       Date:  1993

2.  2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.

Authors:  G Engel; E Müller-Schweinitzer; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

3.  Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine.

Authors:  F De Clerck; Y Somers; L Van Gorp
Journal:  Agents Actions       Date:  1984-12

4.  Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.

Authors:  D Hoffmann; W Wesemann
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  The 5-hydroxytryptamine receptor of blood platelets.

Authors:  A Pletscher; H Affolter
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.

Authors:  M Schächter; D P Geaney; D G Grahame-Smith; P J Cowen; J M Elliott
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

Review 7.  Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.

Authors:  D G Grahame-Smith; D P Geaney; M Schachter; J M Elliott
Journal:  Experientia       Date:  1988-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.